The Effectiveness of a Topical Turmeric-Based Formulation on Contact Dermatitis: A Randomized, Double-Blind, Controlled Trial
Open Access
- 18 August 2026
- journal article
- Published by Brieflands in Iranian Journal of Pharmaceutical Research
- Vol. 25 (1) , e172121
Abstract
Background: Contact dermatitis (CD) affects approximately 15% of adults worldwide, and commonly used treatments are often associated with adverse effects. Traditional medicine sources, including Persian medicine, offer promising alternatives. Based on the principles of Persian medicine, the formulation investigated in this study combines Curcuma longa L., Lawsonia inermis L., and Aristolochia rotunda L. (CLA) to achieve a synergistic therapeutic effect. Objectives: This study aimed to evaluate the efficacy and safety of a 4-week intervention using CLA cream in patients with mild-to-moderate CD. Methods: A randomized, double-blind, placebo-controlled trial was conducted in 64 participants who were assigned to apply either CLA cream or the base cream. Assessments included demographic characteristics, the Dermatology Life Quality Index (DLQI), the Three-Item Severity Score (TIS), and skin parameters, including transepidermal water loss (TEWL), stratum corneum hydration, skin pH, and sebum production. Statistical analyses were performed using repeated-measures analysis of variance with least significant difference post hoc tests, Friedman tests, and Wilcoxon tests. Results: The CLA group showed significantly greater decreases in TEWL and TIS scores than the control group (P = 0.004 and P = 0.003, respectively). In the within-group analysis, sebum production increased significantly after the intervention in the CLA group (P = 0.006). Stratum corneum hydration improved significantly in both groups. Conclusions: A 4-week course of CLA cream appears to ameliorate inflammatory symptoms in patients with mild-to-moderate contact dermatitis. Further large-scale, longer-duration trials are warranted to establish the clinical utility of CLA cream as a complementary therapeutic option.Keywords
This publication has 31 references indexed in Scilit:
- Curcumin: multifaceted biological actions and therapeutic implications—a narrative reviewInflammopharmacology, 2025
- Management of contact dermatitisAllergo Journal, 2023
- Impact in Contact Dermatitis during and after SARS-CoV2 PandemicCurrent Treatment Options in Allergy, 2022
- Curcumol simultaneously induces both apoptosis and autophagy in human nasopharyngeal carcinoma cellsPhytotherapy Research, 2021
- A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patentsPhytotherapy Research, 2021
- Efficacy of a topical formulation of henna (Lawsonia inermis L.) in contact dermatitis in patients using prosthesis: A double-blind randomized placebo-controlled clinical trialComplementary Therapies in Medicine, 2020
- Screening of ferulic acid related compounds as inhibitors of xanthine oxidase and cyclooxygenase-2 with anti-inflammatory activityRevista Brasileira de Farmacognosia, 2016
- Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitisJournal of the American Academy of Dermatology, 2009
- Structural Basis of Phospholipase A2 Inhibition for the Synthesis of Prostaglandins by the Plant Alkaloid Aristolochic Acid from a 1.7 Å Crystal Structure,Biochemistry, 2002
- Scoring the Severity of Atopic Dermatitis: Three Item Severity Score as a Rough System for Daily Practice and as a Pre-screening Tool for StudiesActa Dermato-Venereologica, 1999